These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


300 related items for PubMed ID: 27909723

  • 21. Protective effects of Ginkgo biloba leaf polysaccharide on nonalcoholic fatty liver disease and its mechanisms.
    Yan Z, Fan R, Yin S, Zhao X, Liu J, Li L, Zhang W, Ge L.
    Int J Biol Macromol; 2015 Sep; 80():573-80. PubMed ID: 26047899
    [Abstract] [Full Text] [Related]

  • 22. Target genes associated with lipid and glucose metabolism in non-alcoholic fatty liver disease.
    Li T, Yan H, Geng Y, Shi H, Li H, Wang S, Wang Y, Xu J, Zhao G, Lu X.
    Lipids Health Dis; 2019 Dec 05; 18(1):211. PubMed ID: 31805951
    [Abstract] [Full Text] [Related]

  • 23. Melatonin improves non-alcoholic fatty liver disease via MAPK-JNK/P38 signaling in high-fat-diet-induced obese mice.
    Sun H, Wang X, Chen J, Song K, Gusdon AM, Li L, Bu L, Qu S.
    Lipids Health Dis; 2016 Nov 23; 15(1):202. PubMed ID: 27876064
    [Abstract] [Full Text] [Related]

  • 24. Deletion of Nrf2 leads to hepatic insulin resistance via the activation of NF-κB in mice fed a high-fat diet.
    Liu Z, Dou W, Ni Z, Wen Q, Zhang R, Qin M, Wang X, Tang H, Cao Y, Wang J, Zhao S.
    Mol Med Rep; 2016 Aug 23; 14(2):1323-31. PubMed ID: 27315552
    [Abstract] [Full Text] [Related]

  • 25. 17β-estradiol ameliorates lipotoxicity-induced hepatic mitochondrial oxidative stress and insulin resistance.
    Galmés-Pascual BM, Martínez-Cignoni MR, Morán-Costoya A, Bauza-Thorbrügge M, Sbert-Roig M, Valle A, Proenza AM, Lladó I, Gianotti M.
    Free Radic Biol Med; 2020 Apr 23; 150():148-160. PubMed ID: 32105829
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Lycium ruthenicum extract alleviates high-fat diet-induced nonalcoholic fatty liver disease via enhancing the AMPK signaling pathway.
    Lin J, Zhang Y, Wang X, Wang W.
    Mol Med Rep; 2015 Sep 23; 12(3):3835-3840. PubMed ID: 26017330
    [Abstract] [Full Text] [Related]

  • 28. Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH.
    Amrutkar M, Cansby E, Nuñez-Durán E, Pirazzi C, Ståhlman M, Stenfeldt E, Smith U, Borén J, Mahlapuu M.
    FASEB J; 2015 Apr 23; 29(4):1564-76. PubMed ID: 25609431
    [Abstract] [Full Text] [Related]

  • 29. Effect of Alkaloids from Nelumbinis Plumula against Insulin Resistance of High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Mice.
    Xie Y, Zhang Y, Guo Z, Zeng H, Zheng B.
    J Diabetes Res; 2016 Apr 23; 2016():3965864. PubMed ID: 27761469
    [Abstract] [Full Text] [Related]

  • 30. GADD34-deficient mice develop obesity, nonalcoholic fatty liver disease, hepatic carcinoma and insulin resistance.
    Nishio N, Isobe K.
    Sci Rep; 2015 Aug 28; 5():13519. PubMed ID: 26316333
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice.
    Ideta T, Shirakami Y, Miyazaki T, Kochi T, Sakai H, Moriwaki H, Shimizu M.
    Int J Mol Sci; 2015 Dec 08; 16(12):29207-18. PubMed ID: 26670228
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Lactoferrin attenuates fatty acid-induced lipotoxicity via Akt signaling in hepatocarcinoma cells.
    Morishita S, Tomita K, Ono T, Murakoshi M, Saito K, Sugiyama K, Nishino H, Kato H.
    Biochem Cell Biol; 2015 Dec 08; 93(6):566-73. PubMed ID: 26335364
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.